secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELLAS Life Sciences Group, Inc. (SLS)
CIK:        0001390478
Form:       8-K
Filed at:   2024-08-01T23:59:59+00:00
Accession:  0001104659-24-084952
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SELLAS Life Sciences raises $21M in registered direct offering at premium to market
--------------------------------------------------------------------------------

- Gross proceeds of ~$21M from sale of 15,849,056 units (share or pre-funded warrant + warrant) at $1.325/unit.
- Warrants exercisable for 15,849,056 shares at $1.20, immediately exercisable, five-year term.
- Maxim Group acted as sole placement agent; offering priced at premium to market reflecting investor demand.
- Offering closed on August 1, 2024, under effective shelf registration statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1390478/000110465924084952/0001104659-24-084952-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1390478/000110465924084952/tm2420683d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-084952

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer